DJIA 16,262.56 89.32 0.55%
NASDAQ 4,034.16 0.00 0.00%
S&P 500 1,842.98 12.37 0.68%
market minute promo

15.09 0.15 (1.00%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RPRX $15.09 1.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $15.01
Previous Close $14.94
Daily Range $13.93 - $15.30
52-Week Range $13.93 - $29.79
Market Cap $347.5M
P/E Ratio -11.23
Dividend (Yield) $0.00 (0.0%)
Volume 430,192
Average Daily Volume 344,137
Current FY EPS -$1.55





Repros Therapeutics, Inc. (RPRX) Description

A biopharmaceutical company focused on the development of new drugs to treat hormonal and reproductive system disorders. Website:

News & Commentary

Repros Completes Enrollment for Androxal Study - Analyst Blog

Oversold Conditions For Repros Therapeutics (RPRX)

RPRX Crosses Above Key Moving Average Level

Repros Provides Proellex Update - Analyst Blog

Narrower-than-Expected Q4 Loss at Repros - Analyst Blog

Data on Repros' Androxal - Analyst Blog

Repros Therapeutics (RPRX) Jumps: Stock Rises 6.1% - Tale of the Tape

This Week in Biotech: Sunny, With No Chance of Rain

Clinical data sends one stock up 137% on the week while a global pharmaceutical company announces three major collaborations ... in one day!

Repros Shares Soar After FDA Meeting - Analyst Blog

Biotech Winners: Pernix, Myriad, Repros, OraSure

Pernix, Myriad, Repros and OraSure were four big winners in the biotech space during the past two days. Here's the back story on these pharmaceutical stock pops.

See More RPRX News...

RPRX's Top Competitors

RPRX $15.09 (1.00%)
Current stock: RPRX
JNJ $99.20 (2.12%)
Current stock: JNJ
NVS $83.79 (-0.05%)
Current stock: NVS
RHHBY $36.14 (-0.17%)
Current stock: RHHBY